Company intelligence / Profile preview

Ginger Capital Investment Holding

Hong Kong, China

Ownership: Private
Employees: ~17
Development stage: Other

Overview

Ginger Capital invests in healthcare and biotech companies. Notable investment includes $1.95 million in Bionik Laboratories (a robotics company developing rehabilitation and assistive technology solutions), with clinical data on 1,000+ patients demonstrating efficacy of interactive robotic systems for stroke and neurological rehabilitation.

Therapeutic areas: Neurology
Modalities: Device
Industry: Investors

Partnerships

Bionik Laboratories Corp. (joint venture established May 2017 for exclusive license to sell Bionik's InMotion ARM, InMotion HAND, and InMotion WRIST robotic systems in China)

Beyond the preview

Go deeper on Ginger Capital Investment Holding.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ginger Capital Investment Holding.

Explore the full profile